This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Natalia Jungmann: Innovator in Neurodegenerative Disease Treatment
Introduction
Natalia Jungmann is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurodegenerative diseases. Her innovative work has garnered attention for its potential impact on healthcare.
Latest Patents
Jungmann holds a patent for "Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof." This patent includes compounds that are useful for the treatment and prevention of neurodegenerative diseases, including ophthalmological disorders. The disclosure also features compositions containing these compounds, as well as methods for their use and production. She has 1 patent to her name.
Career Highlights
Jungmann is affiliated with Johns Hopkins University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Some of her notable coworkers include Brendan N Lilley and Byung-Jin Kim, who contribute to her research endeavors and collaborative projects.
Conclusion
Natalia Jungmann is a key figure in the field of neurodegenerative disease research, with a focus on developing effective treatments. Her contributions through her patent and collaborations highlight her dedication to innovation in medicine.